2020 Annual Meeting | C28 - Child Neurology: Metabolic
01:30 PM - 01:35 PM | Introduction |
Introduction and Welcome
Marc C. Patterson, MD, FRACP, FAAN |
01:35 PM - 02:25 PM | Speaker |
Lysosomal Disorders
Marc C. Patterson, MD, FRACP, FAAN |
02:25 PM - 02:30 PM | Q&A |
Questions and Answers
Marc C. Patterson, MD, FRACP, FAAN |
02:30 PM - 03:20 PM | Speaker |
Peroxisomal Disorders
Seyed A. Fatemi, MD, MBA |
03:20 PM - 03:25 PM | Q&A |
Questions and Answers
Seyed A. Fatemi, MD, MBA |
03:25 PM - 03:30 PM | Closing Remarks |
Closing Remarks
|
Marc C. Patterson, MD, FRACP, FAAN | Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care. |
Seyed A. Fatemi, MD, MBA | Dr. Fatemi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for RCO law. The institution of Dr. Fatemi has received research support from Minoryx. The institution of Dr. Fatemi has received research support from Viking Therapeutics. The institution of Dr. Fatemi has received research support from Swanbio Therapeutics . The institution of Dr. Fatemi has received research support from Autobahn Therapeutics. The institution of Dr. Fatemi has received research support from Nuvelution. The institution of Dr. Fatemi has received research support from NIH. The institution of Dr. Fatemi has received research support from A Cure for Ellie Foundation. The institution of Dr. Fatemi has received research support from Brian's Hope Foundation . Dr. Fatemi has received intellectual property interests from a discovery or technology relating to health care. Dr. Fatemi has a non-compensated relationship as a Director (Board member) with ALDConnect that is relevant to AAN interests or activities. |